RECENT PUBLICATIONS ABOUT OUR RESEARCH

Swetlik, C., Cohen, L. S., Kobylski, L. A., Sojka, E. T., Killenberg, P. C., Freeman, M. P., & Viguera, A. C. (2024). Effects of Prenatal Exposure to Second-Generation Antipsychotics on Development and Behavior Among Preschool-Aged Children: Preliminary Results From the National Pregnancy Registry for Psychiatric Medications. The Journal of Clinical Psychiatry, 85(1).

Vanderkruik, R., Freeman, M. P., Dunn, K., Clifford, C., Dimidjian, S., Cohen, L. S. (2023). The challenge of clinical research and suicidality: Participant feedback on a safety protocol. Journal of Clinical Psychiatry. 84(00):22m14737.

Vanderkruik, R., Freeman, M. P., Nonacs, R., Jellinek, M., Gaw, M. L., Clifford, C. A., Bartels, S., & Cohen, L. S. (2023). To screen or not to screen: Are we asking the right question? In response to considering de-implementation of universal perinatal depression screening. General hospital psychiatry, 83, 81–85.

Cohen, L. S., Vanderkruik, R., Arakelian, M., Church, T. R., Dunk, M. M., & Freeman, M. P. (2023). Establishment of the MGH Postpartum Psychosis Project: MGHP3. PloS one, 18(2), e0281133.

Cohen, L. S., Church, T. R., Freeman, M. P., Gaccione, P., Caplin, P. S., Kobylski, L. A., Arakelian, M., Rossa, E. T., Chitayat, D., Hernández-Díaz, S., & Viguera, A. C. (2023). Reproductive Safety of Lurasidone and Quetiapine: Update from the National Pregnancy Registry for Psychiatric Medications. Journal of women’s health (2002), 32(4), 452–462.

Viguera, A. C., McElheny, S. A., Caplin, P. S., Kobylski, L. A., Rossa, E. T., Young, A. V., Gaccione, P., Góez-Mogollón, L., Freeman, M. P., & Cohen, L. S. (2023). Risk of Poor Neonatal Adaptation Syndrome Among Infants Exposed to Second-Generation Atypical Antipsychotics Compared to Antidepressants: Results From the National Pregnancy Registry for Psychiatric Medications. The Journal of clinical psychiatry, 84(1), 22m14492.

Freeman, M. P., Szpunar, M. J., Kobylski, L. A., Harmon, H., Viguera, A. C., & Cohen, L. S. (2022). Pregnancy outcomes after first-trimester exposure to buspirone: prospective longitudinal outcomes from the MGH National Pregnancy Registry for Psychiatric Medications. Archives of women’s mental health, 25(5), 923–928.

Szpunar, M. J., Freeman, M. P., Kobylski, L. A., Caplin, P. S., Gaccione, P., Viguera, A. C., Chitayat, D., Hernández-Díaz, S., & Cohen, L. S. (2022). Risk of major malformations in infants after first-trimester exposure to benzodiazepines: Results from the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications. Depression and anxiety, 39(12), 751–759.

Viguera, A. C., Vanderkruik, R., Gaccione, P., Caplin, P. S., Kobylski, L. A., Freeman, M. P., & Cohen, L. S. (2022). Breastfeeding practices among women taking second-generation antipsychotics: findings from the National Pregnancy Registry for Atypical Antipsychotics. Archives of women’s mental health, 25(2), 511–516.

Baker, A. S., Wales, R., Noe, O., Gaccione, P., Freeman, M. P., & Cohen, L. S. (2022). The Course of ADHD during Pregnancy. Journal of attention disorders, 26(2), 143–148.

Viguera, A. C., Freeman, M. P., Góez-Mogollón, L., Sosinsky, A. Z., McElheny, S. A., Church, T. R., Young, A. V., Caplin, P. S., Chitayat, D., Hernández-Díaz, S., & Cohen, L. S. (2021). Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. The Journal of clinical psychiatry, 82(4), 20m13745.

Freeman, M. P., Viguera, A. C., Góez-Mogollón, L., Young, A. V., Caplin, P. S., McElheny, S. A., Church, T. R., Chitayat, D., Hernández-Díaz, S., & Cohen, L. S. (2021). Reproductive safety of aripiprazole: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. Archives of women’s mental health, 24(4), 659–667.

Joffe, H., de Wit, A., Coborn, J., Crawford, S., Freeman, M., Wiley, A., Athappilly, G., Kim, S., Sullivan, K. A., Cohen, L. S., & Hall, J. E. (2020). Impact of Estradiol Variability and Progesterone on Mood in Perimenopausal Women With Depressive Symptoms. The Journal of clinical endocrinology and metabolism, 105(3), e642–e650.

Freeman, M. P., Goez-Mogollon, L., Sosinsky, A. Z., Church, T. R., McElheny, S. A., Viguera, A. C., & Cohen, L. S. (2019). The impact of obesity on pregnancy outcomes among women with psychiatric disorders: Results from a prospective pregnancy registry. Journal of psychosomatic research, 123, 109735.

Raffi, E. R., Nonacs, R., & Cohen, L. S. (2019). Safety of Psychotropic Medications During Pregnancy. Clinics in perinatology, 46(2), 215–234.

Maki, P. M., Kornstein, S. G., Joffe, H., Bromberger, J. T., Freeman, E. W., Athappilly, G., Bobo, W. V., Rubin, L. H., Koleva, H. K., Cohen, L. S., & Soares, C. N. (2019). Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations. Journal of women’s health (2002), 28(2), 117–134.

Freeman, M. P., Sosinsky, A. Z., Goez-Mogollon, L., Savella, G. M., Moustafa, D., Viguera, A. C., & Cohen, L. S. (2018). Gestational Weight Gain and Pre-pregnancy Body Mass Index Associated With Second-Generation Antipsychotic Drug Use During Pregnancy. Psychosomatics, 59(2), 125–134.

Freeman, M. P., Claypoole, L. D., Burt, V. K., Sosinsky, A. Z., Moustafa, D., Noe, O. B., Cheng, L. J., & Cohen, L. S. (2018). Course of major depressive disorder after pregnancy and the postpartum period. Depression and anxiety, 35(12), 1130–1136.

Cohen, L. S., Góez-Mogollón, L., Sosinsky, A. Z., Savella, G. M., Viguera, A. C., Chitayat, D., Hernández-Díaz, S., & Freeman, M. P. (2018). Risk of Major Malformations in Infants Following First-Trimester Exposure to Quetiapine. The American journal of psychiatry, 175(12), 1225–1231.

Freeman, M. P., Lee, H., Savella, G. M., Sosinsky, A. Z., Marfurt, S. P., Murphy, S. K., & Cohen, L. S. (2018). Predictors of Depressive Relapse in Women Undergoing Infertility Treatment. Journal of women’s health (2002), 27(11), 1408–1414.

Freeman, M. P., Farchione, T., Yao, L., Sahin, L., Taylor, L., Huybrechts, K. F., Nonacs, R., Sosinsky, A. Z., Viguera, A. C., & Cohen, L. S. (2018). Psychiatric Medications and Reproductive Safety: Scientific and Clinical Perspectives Pertaining to the US FDA Pregnancy and Lactation Labeling Rule. The Journal of clinical psychiatry, 79(4), 18ah38120.

Freeman, M. P., Góez-Mogollón, L., McInerney, K. A., Davies, A. C., Church, T. R., Sosinsky, A. Z., Noe, O. B., Viguera, A. C., & Cohen, L. S. (2018). Obstetrical and neonatal outcomes after benzodiazepine exposure during pregnancy: Results from a prospective registry of women with psychiatric disorders. General hospital psychiatry, 53, 73–79.

Park, Y., Hernandez-Diaz, S., Bateman, B. T., Cohen, J. M., Desai, R. J., Patorno, E., Glynn, R. J., Cohen, L. S., Mogun, H., & Huybrechts, K. F. (2018). Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes. The American journal of psychiatry, 175(6), 564–574.

Mitchell, C. M., Srinivasan, S., Plantinga, A., Wu, M. C., Reed, S. D., Guthrie, K. A., LaCroix, A. Z., Fiedler, T., Munch, M., Liu, C., Hoffman, N. G., Blair, I. A., Newton, K., Freeman, E. W., Joffe, H., Cohen, L., & Fredricks, D. N. (2018). Associations between improvement in genitourinary symptoms of menopause and changes in the vaginal ecosystem. Menopause (New York, N.Y.), 25(5), 500–507.

Freeman, M. P., Sosinsky, A. Z., Goez-Mogollon, L., Savella, G. M., Moustafa, D., Viguera, A. C., & Cohen, L. S. (2018). Gestational Weight Gain and Pre-pregnancy Body Mass Index Associated With Second-Generation Antipsychotic Drug Use During Pregnancy. Psychosomatics, 59(2), 125–134.

Raffi, E., Freeman, M. P. (2017) The etiology of premenstrual dysphoric disorder: five interwoven pieces. Current Psychiatry, 9, 20-28.

Panchaud, A., Hernandez-Diaz, S., Freeman, M. P., Viguera, A. C., MacDonald, S. C., Sosinsky, A. Z., & Cohen, L. S. (2017). Use of atypical antipsychotics in pregnancy and maternal gestational diabetes. Journal of psychiatric research, 95, 84–90.

Freeman, M. P., Cheng, L. J., Moustafa, D., Davies, A., Sosinsky, A. Z., Wang, B., Petrillo, L. F., Hogan, C., & Cohen, L. S. (2017). Vortioxetine for major depressive disorder, vasomotor, and cognitive symptoms associated with the menopausal transition. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 29(4), 249–257.

Suri, R., Stowe, Z. N., Cohen, L. S., Newport, D. J., Burt, V. K., Aquino-Elias, A. R., Knight, B. T., Mintz, J., & Altshuler, L. L. (2017). Prospective Longitudinal Study of Predictors of Postpartum-Onset Depression in Women With a History of Major Depressive Disorder. The Journal of clinical psychiatry, 78(8), 1110–1116.

Sosinsky, A. Z., Freeman, M. P., Savella, G. M., Cheng, L. J., Viguera, A. C., & Cohen, L. S. (2017). Delusional Pregnancy Presenting to the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. Journal of clinical psychopharmacology, 37(4), 472–474.

Patorno, E., Huybrechts, K. F., Bateman, B. T., Cohen, J. M., Desai, R. J., Mogun, H., Cohen, L. S., & Hernandez-Diaz, S. (2017). Lithium Use in Pregnancy and the Risk of Cardiac Malformations. The New England journal of medicine, 376(23), 2245–2254.

Huybrechts, K. F., Hernández-Díaz, S., Patorno, E., Desai, R. J., Mogun, H., Dejene, S. Z., Cohen, J. M., Panchaud, A., Cohen, L., & Bateman, B. T. (2016). Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations. JAMA psychiatry, 73(9), 938–946.

Freeman M. P. (2016). Wishful thinking is not effective contraception: family planning, contraception, and safe prescribing. The Journal of clinical psychiatry, 77(4), 523–524.

Cohen, L. S., & Nonacs, R. (2016). Neurodevelopmental Implications of Fetal Exposure to Selective Serotonin Reuptake Inhibitors and Untreated Maternal Depression: Weighing Relative Risks. JAMA psychiatry, 73(11), 1170–1172.

Joffe, H., Crawford, S. L., Freeman, M. P., White, D. P., Bianchi, M. T., Kim, S., Economou, N., Camuso, J., Hall, J. E., & Cohen, L. S. (2016). Independent Contributions of Nocturnal Hot Flashes and Sleep Disturbance to Depression in Estrogen-Deprived Women. The Journal of clinical endocrinology and metabolism, 101(10), 3847–3855.

Freeman, M. P., Sosinsky, A. Z., Moustafa, D., Viguera, A. C., & Cohen, L. S. (2016). Supplement use by women during pregnancy: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. Archives of women’s mental health, 19(3), 437–441.

Meyer, F., Freeman, M. P., Petrillo, L., Barsky, M., Galvan, T., Kim, S., Cohen, L., & Joffe, H. (2016). Armodafinil for fatigue associated with menopause: an open-label trial. Menopause (New York, N.Y.), 23(2), 209–214.

Hogan, C. S., & Freeman, M. P. (2016). Adverse Effects in the Pharmacologic Management of Bipolar Disorder During Pregnancy. The Psychiatric clinics of North America, 39(3), 465–475.

Cohen, L. S., Viguera, A. C., McInerney, K. A., Freeman, M. P., Sosinsky, A. Z., Moustafa, D., Marfurt, S. P., Kwiatkowski, M. A., Murphy, S. K., Farrell, A. M., Chitayat, D., & Hernández-Díaz, S. (2016). Reproductive Safety of Second-Generation Antipsychotics: Current Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. The American journal of psychiatry, 173(3), 263–270.

Cohen, L. S., Viguera, A. C., McInerney, K. A., Kwiatkowski, M. A., Murphy, S. K., Lemon, E. L., & Hernández-Díaz, S. (2015). Establishment of the National Pregnancy Registry for Atypical Antipsychotics. The Journal of clinical psychiatry, 76(7), 986–989.

Freeman, M. P. (2015). Psychotropic medication use during pregnancy: changes to the labeling system and the importance of exposure registries. The Journal of clinical psychiatry, 76(7), 990–991.

Habecker, E., Freeman, M. P. (2015) Awareness and management of obstetrical complications of depression. Current Psychiatry, 14(12):39-44.

Caan, B., LaCroix, A. Z., Joffe, H., Guthrie, K. A., Larson, J. C., Carpenter, J. S., Cohen, L. S., Freeman, E. W., Manson, J. E., Newton, K., Reed, S., Rexrode, K., Shifren, J., Sternfeld, B., & Ensrud, K. (2015). Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial. Menopause (New York, N.Y.), 22(6), 607–615.

Joffe, H., LaCroix, A. Z., & Cohen, L. (2015). Concern about the use of venlafaxine to treat vasomotor symptoms–reply. JAMA internal medicine, 175(4), 658–659.

Freeman, M. P., Cohen, L. S., & McInerney, K. (2014). Omega-3 Fatty acids and gestational length in a high-risk psychiatric population due to psychiatric morbidity and medication exposure during pregnancy. Journal of clinical psychopharmacology, 34(5), 627–632.

Psaros, C., Freeman, M., Safren, S. A., Barsky, M., & Cohen, L. S. (2014). Discontinuation of antidepressants during attempts to conceive: a pilot trial of cognitive behavioral therapy for the prevention of recurrent depression. Journal of clinical psychopharmacology, 34(4), 455–460.

Cohen, L. S., Joffe, H., Guthrie, K. A., Ensrud, K. E., Freeman, M., Carpenter, J. S., Learman, L. A., Newton, K. M., Reed, S. D., Manson, J. E., Sternfeld, B., Caan, B., Freeman, E. W., LaCroix, A. Z., Tinker, L. F., Booth-Laforce, C., Larson, J. C., & Anderson, G. L. (2014). Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial. Menopause (New York, N.Y.), 21(4), 347–354.

Huybrechts, K. F., Palmsten, K., Avorn, J., Cohen, L. S., Holmes, L. B., Franklin, J. M., Mogun, H., Levin, R., Kowal, M., Setoguchi, S., & Hernández-Díaz, S. (2014). Antidepressant use in pregnancy and the risk of cardiac defects. The New England journal of medicine, 370(25), 2397–2407.

Psaros, C., Freeman, M., Safren, S. A., Barsky, M., & Cohen, L. S. (2014). Discontinuation of antidepressants during attempts to conceive: a pilot trial of cognitive behavioral therapy for the prevention of recurrent depression. Journal of clinical psychopharmacology, 34(4), 455–460.

Freeman M. P. (2014). Perinatal psychiatry: an emerging specialty. The Journal of clinical psychiatry, 75(10), 1086–1087.

Joffe, H., Guthrie, K. A., LaCroix, A. Z., Reed, S. D., Ensrud, K. E., Manson, J. E., Newton, K. M., Freeman, E. W., Anderson, G. L., Larson, J. C., Hunt, J., Shifren, J., Rexrode, K. M., Caan, B., Sternfeld, B., Carpenter, J. S., & Cohen, L. (2014). Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial. JAMA internal medicine, 174(7), 1058–1066.

Cohen, L. S., Joffe, H., Guthrie, K. A., Ensrud, K. E., Freeman, M., Carpenter, J. S., Learman, L. A., Newton, K. M., Reed, S. D., Manson, J. E., Sternfeld, B., Caan, B., Freeman, E. W., LaCroix, A. Z., Tinker, L. F., Booth-Laforce, C., Larson, J. C., & Anderson, G. L. (2014). Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial. Menopause (New York, N.Y.), 21(4), 347–354.

Freeman M. P. (2014). ADHD and pregnancy. The American journal of psychiatry, 171(7), 723–728.

Freeman, M. P., Toth, T. L., & Cohen, L. S. (2013). Assisted reproduction and risk of depressive relapse: considerations for treatment. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 25(4), 283–288.

Freeman, M. P., Hirschberg, A. M., Wang, B., Petrillo, L. F., Connors, S., Regan, S., Joffe, H., & Cohen, L. S. (2013). Duloxetine for major depressive disorder and daytime and nighttime hot flashes associated with the menopausal transition. Maturitas, 75(2), 170–174.

Sternfeld, B., LaCroix, A., Caan, B. J., Dunn, A. L., Newton, K. M., Reed, S. D., Guthrie, K. A., Booth-LaForce, C., Sherman, K. J., Cohen, L., Freeman, M. P., Carpenter, J. S., Hunt, J. R., Roberts, M., & Ensrud, K. E. (2013). Design and methods of a multi-site, multi-behavioral treatment trial for menopausal symptoms: the MsFLASH experience. Contemporary clinical trials, 35(1), 25–34.

Joffe, H., Guthrie, K. A., Larson, J., Cohen, L. S., Carpenter, J. S., Lacroix, A. Z., & Freeman, E. W. (2013). Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the menopause strategies: finding lasting answers for symptoms and health research network. Menopause (New York, N.Y.), 20(3), 261–268.

Freeman, M. P., Walker, R., Laughren, T. P., Miller, K. K., & Fava, M. (2013). Female reproductive life cycle and hormones: methodology to improve clinical trials. The Journal of clinical psychiatry, 74(10), 1018–1021.

Freeman, M. P., Joffe, H., Cohen, L. S. (2012). Postpartum depression: Help patients find the right treatment. Current Psychiatry, 14-21.

Ensrud, K. E., Joffe, H., Guthrie, K. A., Larson, J. C., Reed, S. D., Newton, K. M., Sternfeld, B., Lacroix, A. Z., Landis, C. A., Woods, N. F., & Freeman, E. W. (2012). Effect of escitalopram on insomnia symptoms and subjective sleep quality in healthy perimenopausal and postmenopausal women with hot flashes: a randomized controlled trial. Menopause (New York, N.Y.), 19(8), 848–855.

Gibson, C. J., Joffe, H., Bromberger, J. T., Thurston, R. C., Lewis, T. T., Khalil, N., & Matthews, K. A. (2012). Mood symptoms after natural menopause and hysterectomy with and without bilateral oophorectomy among women in midlife. Obstetrics and gynecology, 119(5), 935–941.

Joffe, H., Chang, Y., Dhaliwal, S., Hess, R., Thurston, R., Gold, E., Matthews, K. A., & Bromberger, J. T. (2012). Lifetime history of depression and anxiety disorders as a predictor of quality of life in midlife women in the absence of current illness episodes. Archives of general psychiatry, 69(5), 484–492.

Rogines-Velo, M. P., Heberle, A. E., & Joffe, H. (2012). Effect of medroxyprogesterone on depressive symptoms in depressed and nondepressed perimenopausal and postmenopausal women after discontinuation of transdermal estradiol therapy. Menopause (New York, N.Y.), 19(4), 471–475.

Freeman, M. P., Hibbeln, J. R., Silver, M., Hirschberg, A. M., Wang, B., Yule, A. M., Petrillo, L. F., Pascuillo, E., Economou, N. I., Joffe, H., & Cohen, L. S. (2011). Omega-3 fatty acids for major depressive disorder associated with the menopausal transition: a preliminary open trial. Menopause (New York, N.Y.), 18(3), 279–284.

Freeman, E. W., Guthrie, K. A., Caan, B., Sternfeld, B., Cohen, L. S., Joffe, H., Carpenter, J. S., Anderson, G. L., Larson, J. C., Ensrud, K. E., Reed, S. D., Newton, K. M., Sherman, S., Sammel, M. D., & LaCroix, A. Z. (2011). Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial. JAMA, 305(3), 267–274.

Joffe, H., Petrillo, L. F., Koukopoulos, A., Viguera, A. C., Hirschberg, A., Nonacs, R., Somley, B., Pasciullo, E., White, D. P., Hall, J. E., & Cohen, L. S. (2011). Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition. The Journal of clinical endocrinology and metabolism, 96(7), E1044–E1054.

Cohen, L. S., Wang, B., Nonacs, R., Viguera, A. C., Lemon, E. L., & Freeman, M. P. (2010). Treatment of mood disorders during pregnancy and postpartum. The Psychiatric clinics of North America, 33(2), 273–293.

Freeman, M. P., Mischoulon, D., Tedeschini, E., Goodness, T., Cohen, L. S., Fava, M., & Papakostas, G. I. (2010). Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants. The Journal of clinical psychiatry, 71(6), 682–688.

Joffe, H., Petrillo, L., Viguera, A., Koukopoulos, A., Silver-Heilman, K., Farrell, A., Yu, G., Silver, M., & Cohen, L. S. (2010). Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial. American journal of obstetrics and gynecology, 202(2), 171.e1–171.e11.

Viguera, A. C., Cohen, L. S., Whitfield, T., Reminick, A. M., Bromfield, E., & Baldessarini, R. J. (2010). Perinatal use of anticonvulsants: differences in attitudes and recommendations among neurologists and psychiatrists. Archives of women’s mental health, 13(2), 175–178.

Park, E. R., Chang, Y., Quinn, V., Regan, S., Cohen, L., Viguera, A., Psaros, C., Ross, K., & Rigotti, N. (2009). The association of depressive, anxiety, and stress symptoms and postpartum relapse to smoking: a longitudinal study. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 11(6), 707–714.

Viguera, A. C., Emmerich, A. D., & Cohen, L. S. (2008). Case records of the Massachusetts General Hospital. Case 24-2008. A 35-year-old woman with postpartum confusion, agitation, and delusions. The New England journal of medicine, 359(5), 509–515.

Pearson, K. H., Nonacs, R. M., Viguera, A. C., Heller, V. L., Petrillo, L. F., Brandes, M., Hennen, J., & Cohen, L. S. (2007). Birth outcomes following prenatal exposure to antidepressants. The Journal of clinical psychiatry, 68(8), 1284–1289.

Joffe, H., Soares, C. N., Petrillo, L. F., Viguera, A. C., Somley, B. L., Koch, J. K., & Cohen, L. S. (2007). Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine. The Journal of clinical psychiatry, 68(6), 943–950.

Cohen L. S. (2007). Treatment of bipolar disorder during pregnancy. The Journal of clinical psychiatry, 68 Suppl 9, 4–9.

Viguera, A. C., Whitfield, T., Baldessarini, R. J., Newport, D. J., Stowe, Z., Reminick, A., Zurick, A., & Cohen, L. S. (2007). Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. The American journal of psychiatry, 164(12), 1817–1923.

Viguera, A. C., Newport, D. J., Ritchie, J., Stowe, Z., Whitfield, T., Mogielnicki, J., Baldessarini, R. J., Zurick, A., & Cohen, L. S. (2007). Lithium in breast milk and nursing infants: clinical implications. The American journal of psychiatry, 164(2), 342–345.

Cohen, L. S., Soares, C. N., Vitonis, A. F., Otto, M. W., & Harlow, B. L. (2006). Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Archives of general psychiatry, 63(4), 385–390.

Cohen, L. S., Nonacs, R. M., Bailey, J. W., Viguera, A. C., Reminick, A. M., Altshuler, L. L., Stowe, Z. N., & Faraone, S. V. (2004). Relapse of depression during pregnancy following antidepressant discontinuation: a preliminary prospective study. Archives of women’s mental health, 7(4), 217–221.

Cohen, L. S., Altshuler, L. L., Stowe, Z. N., & Faraone, S. V. (2004). Reintroduction of antidepressant therapy across pregnancy in women who previously discontinued treatment. A preliminary retrospective study. Psychotherapy and psychosomatics, 73(4), 255–258.

Cohen, L. S., Nonacs, R., Viguera, A. C., & Reminick, A. (2004). Diagnosis and treatment of depression during pregnancy. CNS spectrums, 9(3), 209–216.

Cohen L. S. (2003). Gender-specific considerations in the treatment of mood disorders in women across the life cycle. The Journal of clinical psychiatry, 64 Suppl 15, 18–29.

Yonkers, K. A., Wisner, K. L., Stowe, Z., Leibenluft, E., Cohen, L., Miller, L., Manber, R., Viguera, A., Suppes, T., & Altshuler, L. (2004). Management of bipolar disorder during pregnancy and the postpartum period. The American journal of psychiatry, 161(4), 608–620.

Joffe, H., Cohen, L. S., & Harlow, B. L. (2003). Impact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration. American journal of obstetrics and gynecology, 189(6), 1523–1530.

Joffe, H., Soares, C. N., & Cohen, L. S. (2003). Assessment and treatment of hot flushes and menopausal mood disturbance. The Psychiatric clinics of North America, 26(3), 563–580.

Viguera, A. C., Cohen, L. S., Baldessarini, R. J., & Nonacs, R. (2002). Managing bipolar disorder during pregnancy: weighing the risks and benefits. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 47(5), 426–436.

Viguera, A. C., Cohen, L. S., Bouffard, S., Whitfield, T. H., & Baldessarini, R. J. (2002). Reproductive decisions by women with bipolar disorder after prepregnancy psychiatric consultation. The American journal of psychiatry, 159(12), 2102–2104.

Freeman E. W. (2002). Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 7 Suppl 3, 27–43.

Cohen, L. S., Viguera, A. C., Bouffard, S. M., Nonacs, R. M., Morabito, C., Collins, M. H., & Ablon, J. S. (2001). Venlafaxine in the treatment of postpartum depression. The Journal of clinical psychiatry, 62(8), 592–596.

Viguera, A. C., Nonacs, R., Cohen, L. S., Tondo, L., Murray, A., & Baldessarini, R. J. (2000). Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. The American journal of psychiatry, 157(2), 179–184.

Cohen, L. S., Sichel, D. A., Robertson, L. M., Heckscher, E., & Rosenbaum, J. F. (1995). Postpartum prophylaxis for women with bipolar disorder. The American journal of psychiatry, 152(11), 1641–1645.

Cohen, L. S., Friedman, J. M., Jefferson, J. W., Johnson, E. M., & Weiner, M. L. (1994). A reevaluation of risk of in utero exposure to lithium. JAMA, 271(2), 146–150.

BLOG POSTS ABOUT OUR RESEARCH

Psychiatric Disorders During Pregnancy

Bipolar Disorder and Pregnancy

New Research from the CWMH: Relapse of Major Depression during Pregnancy

Neurobehavioral Outcomes in Children Exposed to Lithium in Utero

Bipolar Disorder and Pregnancy: Should Medications Be Discontinued?

New Research:  Treatment Decisions by Pregnant Women with Bipolar Disorder 

Postpartum Psychiatric Disorders

Venlafaxine for Postpartum Depression

New England Journal of Medicine Case Report: Postpartum Psychosis in a Woman with Bipolar Disorder

Postpartum Depressive Symptoms Increase the Risk of Smoking Relapse

New Research from the CWMH: CBT to Reduce Risk of Relapse in Women Attempting to Discontinue Antidepressants

New Study at the CWMH: Brexanolone (SAGE-547) for Postpartum Depression

Breastfeeding and Psychiatric Medications

Can Women Taking Lithium Breastfeed Their Infants?

Anticonvulsant Use in Pregnancy and Nursing: Differences in Recommendations from Psychiatrists vs. Neurologists

Lithium and Breastfeeding

PMS and PMDD

Oral Contraceptives for the Treatment of Premenstrual Mood Symptoms in Women with Depression

Bipolar Disorder and PMS

Infertility and Mental Health

Remote Enrollment Initiated in MGH Study Assessing Mood Symptoms Across Infertility Treatment

Fertility Treatment More Common in Women with Bulimia Nervosa

Menopausal Symptoms

Perimenopause May Be a Time of Risk for New Onset Depression

New Research from the CWMH: Escitalopram (Lexapro) for Hot Flashes

New Research from the CWMH: Progestins Do Not Negatively Affect Mood in Peri- and Postmenopausal Women

New Research from the CWMH: History of Depression and Anxiety Predict Lower Quality of Life in Midlife Women

New Research from the CWMH: Surgically Induced Menopause No Worse than Natural in Terms of Risk for Depression, Anxiety